All ProductsDisplaying Products Alphabetically by Name (B)
| Cat. No. | Product Name / Activity |
|---|---|
| 6764 | B 973B |
| Positive allosteric modulator of α7 nAChRs; analgesic | |
| 6009 | B I09 |
| IRE1 endonuclease inhibitor; cell permeable | |
| 2758 | B-HT 933 dihydrochloride |
| Selective α2 agonist | |
| 6392 | B02 |
| RAD51 recombinase inhibitor | |
| 3606 | BAG 956 |
| Dual PI 3-kinase and PDPK1 (PDK1) inhibitor | |
| 1763 | BAM (8-22) |
| Potent MRGPRX1 agonist | |
| 5737 | BAM 15 |
| Mitochondrial protonophore uncoupler | |
| 2786 | BAPTA |
| Selective calcium chelator | |
| 2787 | BAPTA AM |
| Cell-permeable Ca2+ chelator | |
| 7573 | BAY 1797 New |
| Selective P2X4 antagonist | |
| 7549 | BAY 1816032 |
| Potent and selective BUB1 kinase inhibitor | |
| 6857 | BAY 293 |
| Potent KRas/SOS1 interaction inhibitor | |
| 6906 | BAY 293 Negative Control |
| Negative control for BAY 293 (Cat. No. 6857) | |
| 5970 | BAY 299 |
| Potent and selective BRD1 and TAF1 inhibitor | |
| 4430 | BAY 41-2272 |
| Soluble guanylyl cyclase (sGC) activator | |
| 5708 | BAY 41-8543 |
| Guanylyl cyclase (sGC) stimulator | |
| 6052 | BAY 58-2667 hydrochloride |
| Potent soluble guanylyl cyclase (sGC) activator | |
| 5991 | BAY 598 |
| Potent and selective SMYD2 inhibitor | |
| 4472 | BAY 60-6583 |
| Potent partial A2B agonist; cardioprotective | |
| 6561 | BAY 6035 |
| Potent and selective SMYD3 inhibitor | |
| 6389 | BAY 677 |
| Inactive control for BAY 678 (Cat.No.5706) | |
| 5706 | BAY 678 |
| Potent and selective cell-permeable human neutrophil elastase (HNE) inhibitor | |
| 6562 | BAY 707 |
| Potent and selective MTH1 inhibitor | |
| 6817 | BAY 8002 |
| Potent dual MCT1/2 inhibitor; orally bioavailable | |
| 6579 | BAY 826 |
| Potent Tie2 inhibitor | |
| 6980 | BAY 87-2243 |
| Mitochondrial complex I inhibitor | |
| 6199 | BAY 876 |
| Potent and selective GLUT1 inhibitor | |
| 2732 | BAY-u 3405 |
| Dual TP/DP2 (CRTH2) receptor antagonist | |
| 5266 | BAZ2-ICR |
| Selective BAZ2 inhibitor | |
| 4372 | BC 11 hydrobromide |
| Selective urokinase (uPA) inhibitor | |
| 6791 | BC-LI-0186 |
| Leucyl-tRNA synthase (TRS)/Ras-related GTP-binding protein D (RagD) interaction inhibitor | |
| 5027 | BCH |
| LAT1 inhibitor | |
| 7481 | BCI New |
| DUSP6 and DUSP1 inhibitor | |
| 3875 | BCTC |
| TRPV1 antagonist | |
| 0956 | BD 1047 dihydrobromide |
| σ1 selective antagonist | |
| 0883 | BD 1063 dihydrochloride |
| Selective σ1 ligand, putative antagonist | |
| 3579 | 5-BDBD |
| Potent and selective P2X4 antagonist | |
| 2837 | BDNF (human) |
| Activates TrkB and p75 receptors | |
| 5469 | BDY 650-X, SE |
| Far-red BDY (BODIPY® or boron-dipyrromethene) fluorescent dye for the labeling of amines; supplied as NHS ester | |
| 7483 | BDY FL VH032 |
| High-affinity VHL fluorescent probe for TR-FRET and FP assays | |
| 5465 | BDY FL, SE |
| Green BDY (BODIPY® or boron-dipyrromethene) fluorescent dye for the labeling of amines; supplied as NHS ester | |
| 4778 | BETP |
| Positive allosteric modulator of GLP-1 receptors | |
| 3743 | BF 2649 hydrochloride |
| Potent and selective H3 inverse agonist | |
| 6246 | BF 738735 |
| Potent and selective PI 4-kinase IIIβ inhibitor; broad spectrum enterovirus replication inhibitor | |
| 0348 | 2-BFI hydrochloride |
| Potent, selective I2 ligand. Putative agonist | |
| 5327 | BGC 20-1531 hydrochloride |
| High affinity and selective EP4 antagonist | |
| 3326 | BGC 20-761 |
| High affinity 5-HT6 antagonist | |
| 6703 | BGP 15 |
| PARP inhibitor; cytoprotectant | |
| 3313 | rac BHFF |
| Potent and selective postitive allosteric modulator of GABAB receptors | |
| 6116 | BHPI |
| ERα antagonist; also activates unfolded protein response; active in vivo | |
| 6518 | BI 01383298 |
| Potent and selective SLC13A5 (Na+/citrate cotransporter) inhibitor | |
| 4641 | BI 6015 |
| Hepatocyte nuclear factor 4α (HNF4α) antagonist | |
| 5300 | BI 605906 |
| Selective IKKβ inhibitor | |
| 3314 | BI 78D3 |
| Selective, competitive JNK inhibitor | |
| 6665 | BI 9321 |
| Nuclear receptor-binding SET domain (NSD) 3 antagonist; selectively binds PWWP1 domain | |
| 5590 | BI 9564 |
| Potent and selective BRD9 and BRD7 inhibitor; orally active | |
| 7466 | BI dihydrochloride |
| DFHBI derivative for imaging of RNA in living cells that bind Broccoli aptamers | |
| 6141 | BI-6901 |
| Potent and selective CCR10 antagonist | |
| 4561 | BIBN 4096 |
| Potent and selective CGRP antagonist | |
| 2412 | BIBO 3304 trifluoroacetate |
| Highly selective NPY Y1 receptor antagonist | |
| 2707 | BIBP 3226 trifluoroacetate |
| Mixed NPY Y1 and NPFF receptor antagonist | |
| 2981 | BIBR 1532 |
| Selective telomerase inhibitor | |
| 7377 | BIIE 0246 hydrochloride |
| Potent, selective and competitive non-peptide NPY Y2 receptor antagonist; active in vivo | |
| 4374 | BIMU 8 |
| Potent 5-HT4 agonist | |
| 4048 | BINA |
| Selective positive allosteric modulator of mGlu2 receptors | |
| 3194 | BIO |
| Potent GSK-3 inhibitor; also inhibits cdks | |
| 3910 | BIO 1211 |
| Selective α4β1 (VLA-4) inhibitor | |
| 5051 | BIO 5192 |
| Highly potent and selective inhibitor of integrin α4β1 (VLA-4) | |
| 3874 | BIO-acetoxime |
| Selective GSK-3α/β inhibitor | |
| 5989 | BIRB 796 |
| High affinity and selective p38 kinase inhibitor | |
| 4776 | BIRT 377 |
| Potent negative allosteric modulator of LFA-1 | |
| 3364 | BIX 01294 |
| GLP and G9a inhibitor | |
| 4842 | BIX 02189 |
| Selective MEK5 and ERK5 inhibitor | |
| 5512 | BIX NHE1 inhibitor |
| Potent and selective NHE1 inhibitor | |
| 3797 | BL 1249 |
| K2P2.1 (TREK-1) and K2P10.1 (TREK-2) activator | |
| 2538 | L-BMAA hydrochloride |
| Neurotoxic amino acid | |
| 5417 | BMH 21 |
| RNA polymerase I inhibitor; also p53 pathway activator | |
| 5488 | BML 111 |
| FPR2 (lipoxin A4 receptor) agonist | |
| 2665 | BMS 191011 |
| Potent KCa1.1 (BK) channel opener | |
| 3242 | BMS 193885 |
| Potent, competitive NPY Y1 receptor antagonist | |
| 3660 | BMS 195614 |
| Selective RARα antagonist | |
| 5654 | BMS 265246 |
| Cdk inhibitor; potently inhibits cdk1 and cdk2 | |
| 2870 | BMS 299897 |
| Potent γ-secretase inhibitor | |
| 4609 | BMS 303141 |
| ATP citrate lyase inhibitor; orally bioavailable | |
| 5258 | BMS 309403 |
| Potent and selective FABP4 inhibitor | |
| 4806 | BMS 345541 |
| Selective allosteric inhibitor of IKK; anti-inflammatory | |
| 6878 | BMS 466442 |
| Potent and selective inhibitor of asc-1 | |
| 3509 | BMS 493 |
| Pan-RAR inverse agonist | |
| 4774 | BMS 536924 |
| Dual IR/IGF1R inhibitor | |
| 5274 | BMS 564929 |
| Highly potent and muscle-selective androgen receptor (AR) agonist | |
| 5492 | BMS 566419 |
| Inosine monophosphatase dehydrogenase (IMPDH) inhibitor | |
| 5022 | BMS 599626 dihydrochloride |
| Potent, selective EGFR and ErbB2 inhibitor | |
| 6069 | BMS 605541 |
| Potent VEGFR-2 inhibitor | |
| 4970 | BMS 688521 |
| Potent inhibitor of the LFA-1/ICAM interaction | |
| 3505 | BMS 753 |
| RARα-selective agonist | |
| 3410 | BMS 961 |
| Selective RARγ agonist | |
| 6974 | BMS 986094 |
| Inhibitor of HCV RNA-dependent RNA polymerase (RdRP; NS5b); potent hepatitis C virus (HCV) replication inhibitor | |
| 5983 | BMS 986187 |
| Potent positive allosteric modulator of δ receptors | |
| 3129 | BMS CCR2 22 |
| High affinity, potent CCR2 antagonist | |
| 5123 | BMX-IN-1 |
| Potent and irreversible BMX inhibitor | |
| 6047 | BOP |
| Dual α9β1/α4β1 integrin inhibitor; preferentially mobilizes HSCs | |
| 6996 | BOP-JF549 |
| Yellow fluorescent dual α9β1/α4β1 integrin inhibitor comprising BOP conjugated to Janelia Fluor® 549; fluorogenic; photostable | |
| 6997 | BOP-JF646 |
| Red fluorescent dual α9β1/α4β1 integrin inhibitor comprising BOP conjugated to Janelia Fluor® 646; fluorogenic; photostable | |
| 5301 | BPTES |
| Selective allosteric glutaminase (GLS1) inhibitor | |
| 6078 | BPTU |
| P2Y1 allosteric antagonist | |
| 1500 | BQ 788 sodium salt |
| Selective ETB antagonist | |
| 1188 | BQ-123 |
| Selective ETA antagonist | |
| 1189 | BQ-3020 |
| Selective ETB agonist | |
| 6872 | BQCA |
| Positive allosteric modulator of M1 receptors | |
| 5312 | BRACO 19 trihydrochloride |
| Telomerase inhibitor | |
| 7153 | BRD 0539 |
| Cell permeable and reversible Cas9 inhibitor | |
| 6438 | BRD 6989 |
| Cdk8 inhibitor; enhances IL-10 production | |
| 4037 | BRD 7389 |
| Ribosomal S6 kinase inhibitor | |
| 6284 | BRD 73954 |
| Dual histone deacetylase (HDAC) 6/8 inhibitor | |
| 6040 | BRD 9757 |
| Potent and selective HDAC6 inhibitor | |
| 7319 | BRD PHOTAC-I-3 |
| Photoswitchable BET bromodomain Degrader (PHOTAC) | |
| 0948 | BRL 37344, sodium salt |
| β3 agonist | |
| 1133 | BRL 44408 maleate |
| Selective α2A antagonist | |
| 2237 | BRL 50481 |
| Selective PDE7 inhibitor | |
| 0699 | BRL 52537 hydrochloride |
| Potent and selective κ agonist | |
| 5608 | BS 181 dihydrochloride |
| Selective cdk7 inhibitor | |
| 6921 | BSJ-03-123 |
| Selective Cdk6 Degrader (PROTAC®) | |
| 6938 | BSJ-03-204 |
| Selective Cdk4/6 Degrader (PROTAC®) | |
| 6937 | BSJ-04-132 |
| Selective Cdk4 Degrader (PROTAC®) | |
| 7528 | BSJ-4-116 |
| Selective CDK12 PROTAC® Degrader | |
| 7529 | BSJ-4-116-NC |
| Negative control for BSJ-4-116 (Cat. No. 7528). | |
| 6922 | BSJ-Bump |
| Negative control for BSJ-03-123 (Cat. No. 6921) | |
| 5399 | BTB1 |
| Selective and ATP-competitive Kif18A inhibitor | |
| 6940 | BTD |
| Selective TRPC5 activator | |
| 1870 | BTS |
| Selective inhibitor of skeletal muscle myosin II ATPase activity | |
| 4724 | BTT 3033 |
| Selective inhibitor of integrin α2β1 | |
| 4204 | BTZO 1 |
| MIF binder | |
| 0725 | BU 224 hydrochloride |
| Potent, selective I2 ligand. Putative antagonist | |
| 2176 | BVT 948 |
| Non-competitive protein tyrosine phosphatase inhibitor | |
| 1663 | BW 373U86 |
| Potent, selective non-peptide δ agonist | |
| 1059 | BW 723C86 hydrochloride |
| 5-HT2B agonist | |
| 5545 | BX 430 |
| Selective P2X4 allosteric antagonist | |
| 3496 | BX 471 |
| Potent, selective CCR1 antagonist | |
| 2769 | BX 513 hydrochloride |
| Selective CCR1 antagonist | |
| 4318 | BX 795 |
| PDPK1 (PDK1) inhibitor | |
| 0796 | (R)-Baclofen |
| Selective GABAB agonist; active enantiomer of (RS)-Baclofen (Cat. No. 0417) | |
| 0417 | (RS)-Baclofen |
| Selective GABAB agonist | |
| 1334 | Bafilomycin A1 |
| H+-ATPase (vacuolar) inhibitor | |
| 5585 | Balicatib |
| Potent and selective cathepsin K inhibitor | |
| 4219 | Banoxantrone dihydrochloride |
| Prodrug topoisomerase II inhibitor | |
| 7222 | Baricitinib |
| Highly potent JAK1 and JAK2 inhibitor; also inhibits JAK3 and Tyk2 | |
| 2961 | Batimastat |
| Potent, broad spectrum MMP inhibitor | |
| 2160 | Bax channel blocker |
| Allosteric inhibitor of Bax channel activation | |
| 1743 | Bay 11-7085 |
| Irreversible inhibitor of TNF-α-induced IκBα phosphorylation | |
| 1744 | Bay 11-7821 |
| E2 ubiquitin (Ub) conjugating enzymes inhibitor | |
| 2501 | Bay 36-7620 |
| mGlu1 inverse agonist | |
| 2711 | Bay 55-9837 |
| Potent and selective VPAC2 agonist | |
| 1544 | (±)-Bay K 8644 |
| CaV1.x activator | |
| 1545 | (R)-(+)-Bay K 8644 |
| CaV1.x blocker; (R)-(+)-enantiomer of (±)-Bay K 8644; also TMEM176B inhibitor | |
| 1546 | (S)-(-)-Bay K 8644 |
| CaV1.x activator; (S)-(-)-enantiomer of (±)-Bay K 8644 | |
| 5263 | Bazedoxifene acetate |
| Potent and selective estrogen receptor modulator (SERM) | |
| 3681 | Bendamustine hydrochloride |
| Cytostatic agent; exhibits DNA alkylating and purine analog properties | |
| 3380 | Benzamil |
| NCX inhibitor, Deg/ENaC channel blocker; amiloride (Cat. No. 0890) derivative | |
| 4117 | Bepridil hydrochloride |
| Non-selective Ca2+ channel blocker; also NCX inhibitor | |
| 4180 | Beraprost sodium |
| Potent prostacyclin IP receptor agonist | |
| 1956 | Bestatin |
| Aminopeptidase inhibitor | |
| 0906 | Betaxolol hydrochloride |
| Selective β1 antagonist | |
| 3906 | Betulinic acid |
| Antitumor and anti-HIV agent; activates NF-κB. Also TGR5 agonist | |
| 5819 | Bexarotene |
| Potent and selective RXR agonist | |
| 3389 | Bicalutamide |
| Non-steroidal androgen receptor antagonist | |
| 2503 | (-)-Bicuculline methiodide |
| GABAA antagonist; more water soluble version of (+)-bicuculline (Cat. No. 0130) | |
| 0109 | (-)-Bicuculline methobromide |
| GABAA antagonist; more water soluble version of (+)-bicuculline (Cat. No. 0130) | |
| 0131 | (-)-Bicuculline methochloride |
| GABAA antagonist; more water soluble version of (+)-bicuculline (Cat. No. 0130) | |
| 0130 | (+)-Bicuculline |
| Potent GABAA antagonist | |
| 0767 | Bifemelane hydrochloride |
| Non-selective MAO inhibitor | |
| 6304 | BigLEN (mouse) |
| GPR171 agonist | |
| 3349 | Biocytin |
| Versatile marker for neuroanatomical investigations | |
| 6571 | Biotin-11-dUTP |
| Biotin-labeled dUTP | |
| 6572 | Biotin-LC-NAD+ |
| Biotinylated analog of β-NAD+; commonly used reagent in LSD1 and PARP1 assays | |
| 6573 | Biotin-NAD+ |
| Biotinylated-NAD+; substrate for ADP-ribosylation | |
| 7524 | Biotin-PEG3-Azide New |
| Biotin with PEG linker and reactive click handle | |
| 6241 | Biotinyl Tyramide |
| Reagent widely used for signal amplification in IHC and FISH | |
| 2853 | Biperiden hydrochloride |
| Muscarinic receptor antagonist; some selectivity for M1 | |
| 5348 | 6,8-Bis(benzylthio)octanoic acid |
| PDH and KGDH inhibitor | |
| 4128 | Bisindolylmaleimide II |
| Potent PKC inhibitor; also potent nAChR antagonist | |
| 5502 | Blasticidin S HCl |
| Antibiotic; selection reagent for bis, bsr and BSD transformed cells | |
| 1853 | (R)-(+)-Blebbistatin |
| Selective inhibitor of myosin II ATPase activity. Inactive enantiomer of (±)-blebbistatin (Cat. No. 1760) | |
| 1852 | (S)-(-)-Blebbistatin |
| Selective inhibitor of myosin II ATPase activity. Active enantiomer of (±)-blebbistatin (Cat. No. 1760) | |
| 1760 | (±)-Blebbistatin |
| Selective inhibitor of myosin II ATPase activity | |
| 5255 | 6-Bnz-cAMP sodium salt |
| Cell permeable cAMP analog | |
| 6977 | Bobcat339 |
| Ten-eleven translocation methylcytosine dioxygenase (TET) inhibitor | |
| 3730 | Boc-MLF |
| FPR1 antagonist | |
| 4706 | Borrelidin |
| Antiangiogenic; inhibits threonyl-tRNA synthetase | |
| 7282 | Bortezomib |
| High affinity proteasome inhibitor | |
| 6232 | Bosentan |
| High affinity dual ETA and ETB receptor antagonist;orally bioavailable | |
| 4361 | Bosutinib |
| Dual Src-Abl inhibitor; antiproliferative | |
| 5217 | Bovine Serum Albumin |
| BSA (bovine serum albumin) is a blocking buffer for IHC, ICC, ELISA and Western blotting; used to block non-specific antibody binding. Commonly used in cell culture | |
| 3004 | Bradykinin |
| Endogenous agonist at bradykinin receptors (B2 > B1) | |
| 3225 | Lys-[Des-Arg9]Bradykinin |
| Selective B1 agonist | |
| 3229 | [Phe8Ψ(CH-NH)-Arg9]-Bradykinin |
| Selective B2 agonist | |
| 3522 | Brain natriuretic peptide (1-32) (human) |
| Endogenous peptide agonist at ANP receptor A (NPR1) | |
| 1231 | Brefeldin A |
| Disrupts protein translocation to Golgi | |
| 6196 | Brequinar sodium |
| Potent and selective DHODH inhibitor | |
| 3568 | Bretazenil |
| Benzodiazepine partial agonist | |
| 7271 | Brivaracetam |
| SV2A ligand; antiepileptic | |
| 1140 | 8-Bromo-cAMP, sodium salt |
| Cell-permeable cAMP analog | |
| 1089 | 8-Bromo-cGMP, sodium salt |
| cGMP analog; activates PKG | |
| 7686 | BromoTag® AGB1 |
| Potent and selective Degrader of Brd4BD2 L387A fusion proteins (BromoTag®) | |
| 7688 | BromoTag® AGB3 |
| Selective Degrader of Brd4BD2 L387A fusion proteins (BromoTag®) | |
| 7687 | BromoTag® cis-AGB1 |
| Negative control for BromoTag® AGB1 (Cat.No. 7686) | |
| 0427 | Bromocriptine mesylate |
| D2-like agonist (D2>D3>D4) | |
| 3549 | 3-Bromocytisine |
| Potent α4β4, α4β2 and α7 nAChR agonist | |
| 5015 | 5-BrdU |
| Synthetic thymidine analog; used for cell proliferation assays | |
| 0735 | 3-Bromo-7-nitroindazole |
| Selective nNOS inhibitor | |
| 5218 | Bromophenol Blue |
| Dye used in gel loading buffers | |
| 7512 | 3-Bromopyruvate |
| MCT1 inhibitor; also inhibits hexokinase II | |
| 4758 | Bromosporine |
| Broad spectrum bromodomain inhibitor | |
| 4316 | Bropirimine |
| Immunomodulatory and antitumor compound | |
| 2383 | Bryostatin 1 |
| Protein kinase C activator | |
| 2671 | Budesonide |
| Synthetic glucocorticoid; anti-inflammatory and chemopreventive | |
| 3108 | Bumetanide |
| Na+/2Cl-/K+ (NKCC) symporter inhibitor | |
| 2133 | α-Bungarotoxin |
| Selective α7 nAChR antagonist | |
| 2808 | Buprenorphine hydrochloride |
| NOP agonist; also displays mixed action δ, κ and μ receptors | |
| 2831 | Bupropion hydrochloride |
| Non-selective inhibitor of dopamine and noradrenalin transporters | |
| 5791 | Bz 423 |
| ATP synthase inhibitor; proapoptotic | |
| 3312 | BzATP triethylammonium salt |
| Photoaffinity label for ATPase; also P2X7 agonist and P2X1/P2Y1 partial agonist | |
| 6786 | BzF |
| Photoreactive unnatural amino acid; photo-crosslinker |
Tocris Products by Catalog Number
0100020003000400050006000700080009001000110012001300140015001600170018001900200021002200230024002500260027002800290030003100320033003400350036003700380039004000410042004300440045004600470048004900500051005200530054005500560057005800590060006100620063006400650066006700680069007000710072007300740075007600770078007900